Boston Scientific Corp. (BSX)
48.18
-1.68
(-3.38%)
USD |
NYSE |
Aug 26, 16:00
48.33
+0.16
(+0.32%)
After-Hours: 17:08
Boston Scientific EPS Diluted (Quarterly) : 0.615 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.615 |
| March 31, 2026 | 0.897 |
| December 31, 2025 | 0.4493 |
| September 30, 2025 | 0.5048 |
| June 30, 2025 | 0.5336 |
| March 31, 2025 | 0.4514 |
| December 31, 2024 | 0.3798 |
| September 30, 2024 | 0.3153 |
| June 30, 2024 | 0.2183 |
| March 31, 2024 | 0.3341 |
| December 31, 2023 | 0.3413 |
| September 30, 2023 | 0.3424 |
| June 30, 2023 | 0.1792 |
| March 31, 2023 | 0.2075 |
| December 31, 2022 | 0.0874 |
| September 30, 2022 | 0.1208 |
| June 30, 2022 | 0.1711 |
| March 31, 2022 | 0.0674 |
| December 31, 2021 | 0.0557 |
| September 30, 2021 | 0.2821 |
| June 30, 2021 | 0.1201 |
| March 31, 2021 | 0.2285 |
| December 31, 2020 | 0.0958 |
| September 30, 2020 | -0.1181 |
| June 30, 2020 | -0.1084 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0078 |
| December 31, 2019 | 2.828 |
| September 30, 2019 | 0.0892 |
| June 30, 2019 | 0.11 |
| March 31, 2019 | 0.30 |
| December 31, 2018 | 0.27 |
| September 30, 2018 | 0.31 |
| June 30, 2018 | 0.40 |
| March 31, 2018 | 0.21 |
| December 31, 2017 | -0.45 |
| September 30, 2017 | 0.20 |
| June 30, 2017 | 0.105 |
| March 31, 2017 | 0.21 |
| December 31, 2016 | 0.09 |
| September 30, 2016 | 0.17 |
| June 30, 2016 | -0.15 |
| March 31, 2016 | 0.15 |
| December 31, 2015 | -0.11 |
| September 30, 2015 | -0.15 |
| June 30, 2015 | 0.0749 |
| March 31, 2015 | -0.0008 |
| December 31, 2014 | -0.23 |
| September 30, 2014 | 0.03 |
| June 30, 2014 | 0.003 |
| March 31, 2014 | 0.10 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.5324 |
| Becton, Dickinson & Co. | 1.370 |
| Penumbra, Inc. | 0.8797 |
| Insulet Corp. | 1.066 |
| Intuitive Surgical, Inc. | 2.290 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 905.00M |
| Revenue (Quarterly) | 5.442B |
| Total Expenses (Quarterly) | 4.535B |
| Enterprise Value | 84.35B |
| Gross Profit Margin (Quarterly) | 66.50% |
| Profit Margin (Quarterly) | 16.63% |
| Earnings Yield | 5.12% |
| Operating Earnings Yield | 6.38% |
| Normalized Earnings Yield | 5.358 |